Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 2116 AL 2130

Is the Era of One-Size-Fits-All Alzheimer's Treatment Officially Over?

Verma S, Kumari K, Kesharwani P, Verma K, Dwivedi J, Paliwal S, Sharma S.

J Mol Neurosci. 2025 Dec 22;76(1):3. doi: 10.1007/s12031-025-02445-1.

Method comparison and re-calibration of three top-used immunoassays and one LC-MS/MS assay for four core cerebrospinal fluid biomarkers of Alzheimer's disease: an explorative study for harmonization

Zou Y, Ma X, Mao C, Chu S, Wang T, Jin W, Wang Y, Yu S, Gao J, Qiu L.

Clin Chim Acta. 2025 Jul 15;575:120352. doi: 10.1016/j.cca.2025.120352. Epub 2025 May 11.

Associations of depressive symptoms and cortisol with cognitive performance among memory clinic patients

Adedeji DO, Holleman J, Johansson L, Kåreholt I, Aspö M, Hagman G, Akenine U, Overton M, Solomon A, Kivipelto M, Sindi S, Sacuiu SF.

Int Psychogeriatr. 2025 Mar;37(2):100009. doi: 10.1016/j.inpsyc.2024.100009. Epub 2024 Dec 4.

Neurodegeneration and glial activation related blood biomarkers in Alzheimer's disease: A systematic review and an updated meta- analysis

Ebrahimi R, Salehi Amniyeh Khozani AA, Masouri MM, Seifi M, Hashempoor A, Mohammad Soltani S, Noori S.

Exp Gerontol. 2025 Dec;212:112960. doi: 10.1016/j.exger.2025.112960. Epub 2025 Nov 14.

Effect of probiotics on cognitive function and cardiovascular risk factors in mild cognitive impairment and Alzheimer's disease: an umbrella meta-analysis

Xiao B, Fu L, Yang Z, Yu G.

J Health Popul Nutr. 2025 Apr 8;44(1):109. doi: 10.1186/s41043-025-00816-3.

Cerebrospinal Fluid β-Amyloid and τ Levels in Patients With Iatrogenic Cerebral Amyloid Angiopathy, Sporadic Cerebral Amyloid Angiopathy, Alzheimer Disease, and Controls

Jensen-Kondering U, Margraf NG, Pikija S, Rak-Frattner K, Malojcic B, Frol S, Pretnar-Oblak J, de la Riva P, Albajar Gomez I, DiFrancesco JC, Bersano A, Kuhlenbäumer G, Storti B.

J Am Heart Assoc. 2025 Aug 5;14(15):e041908. doi: 10.1161/JAHA.125.041908. Epub 2025 Jul 29.

ADNI Biomarker Core: A review of progress since 2004 and future challenges

Shaw LM, Korecka M, Lee EB, Cousins KAQ, Vanderstichele H, Schindler SE, Tosun D, DeMarco ML, Brylska M, Wan Y, Burnham S, Sciulli A, Vulaj A, Tropea TF, Chen-Plotkin A, Wolk DA; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2025 Jan;21(1):e14264. doi: 10.1002/alz.14264. Epub 2024 Nov 30.

Diverse role of S100 calcium-binding protein B in alzheimer's disease: pathological mechanisms and therapeutic implications

Sarkar S, Porel P, Kosey S, Aran KR.

Inflammopharmacology. 2025 Apr;33(4):1803-1816. doi: 10.1007/s10787-025-01697-y. Epub 2025 Mar 9.

Discussing the Interplay of Social Determinants of Health, Aging, and Alzheimer's Biomarkers in U.S. Latinos

Martinez JE, Perales-Puchalt J, Rodriguez MJ, Rosselli M, Salazar C, Marquez DX, Lamar M, Vila-Castelar C, Rascovsky K, O'Bryant S, Vintimilla R, Díaz-Santos M, Velez Uribe I, Quiroz YT, Llibre-Guerra JJ; US Consortium of Aging, Dementia & Latino Studies (CADLAS).

J Gerontol A Biol Sci Med Sci. 2025 Jul 24;80(8):glaf020. doi: 10.1093/gerona/glaf020.

Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease

Grill JD, Tam S, Thai G, Vides B, Pierce AL, Green K, Gillen DL, Teng E, Kremen S, Beigi M, Rissman RA, Léger GC, Balasubramanian A, Revta C, Morrison R, Jennings R, Pa J, Zhang J, Jin S, Messer K, Feldman HH.

Neurology. 2025 Jan 14;104(1):e210152. doi: 10.1212/WNL.0000000000210152. Epub 2024 Dec 13.

Is early-phase amyloid PET ready for use as neurodegeneration marker?

Boccalini C, Garibotto V.

J Alzheimers Dis. 2025 Oct;107(4):1411-1414. doi: 10.1177/13872877251366671. Epub 2025 Aug 14.

Menopausal hormone therapy is associated with worse levels of Alzheimer's disease biomarkers in APOE ε4-carrying women: An observational study

Jauregi-Zinkunegi A, Gleason CE, Bendlin B, Okonkwo O, Hermann BP, Blennow K, Zetterberg H, Hogervorst E, Johnson SC, Langhough R, Mueller KD, Bruno D.

Alzheimers Dement. 2025 Feb;21(2):e14456. doi: 10.1002/alz.14456. Epub 2025 Jan 9.

Importance of Gut Microbiota Dysbiosis and Circadian Disruption-Associated Biomarkers in Emergence of Alzheimer's Disease

Kaur S, Kumari D, Dandekar MP.

Mol Neurobiol. 2025 May;62(5):6308-6316. doi: 10.1007/s12035-024-04685-5. Epub 2025 Jan 7.

Diagnostic utility of electrophysiological markers for early and differential diagnosis of Alzheimer's, Frontotemporal, and Lewy Body dementias: A systematic review

De Keulenaer S, Van Mossevelde S, Van den Bossche T, Crosiers D, Cras P, Ellender T, Bruffaerts R.

Neurol Sci. 2025 Sep;46(9):4103-4120. doi: 10.1007/s10072-025-08207-6. Epub 2025 May 17.

Comparison of diagnostic accuracy of Alzheimer's disease cerebrospinal fluid core biomarkers using INNOTEST, Lumipulse G, and Elecsys assays: Insights from the PUMCH dementia cohort study

Mao C, Zou Y, Wang T, Sha L, Wu M, Chu S, Jin W, Li B, Huang Y, Qiu Y, Bao J, Wang W, Jiang Y, Dong L, Feng F, Huo L, Teunissen C, Qiu L, Gao J.

J Alzheimers Dis. 2025 Nov;108(2):746-756. doi: 10.1177/13872877251379084. Epub 2025 Sep 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias